Clinical trial

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

NCT03884556

Study summary

ClinicalTrials.gov

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention TTX-030 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pembrolizumab Normalized identity: pembrolizumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Gemcitabine Normalized identity: gemcitabine View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention nab paclitaxel Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-04-10

PhasePHASE1

Conditions

Solid Tumorunresolved

Lymphomaverified · MONDO: lymphoma

Interventions

TTX-030DRUG

PembrolizumabDRUG · verified · RxNorm: pembrolizumab

GemcitabineDRUG · verified · RxNorm: gemcitabine

nab paclitaxelDRUG

Sponsors & collaborators

Trishula Therapeutics, Inc.lead sponsor

Mapped research locations

New YorkNew York, United States2 MiamiFlorida, United States1 San AntonioTexas, United States1 NashvilleTennessee, United States1 San FranciscoCalifornia, United States1 ClevelandOhio, United States1 PittsburghPennsylvania, United States1 OmahaNebraska, United States1 Salt Lake CityUtah, United States1 The BronxNew York, United States1 SacramentoCalifornia, United States1 LouisvilleKentucky, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03884556 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.